Evidence-Based Complementary and Alternative Medicine

The Complementary and Alternative Medicine for Antithrombosis


Publishing date
15 May 2015
Status
Published
Submission deadline
26 Dec 2014

Lead Editor

1Chongqing University, Chongqing, China

2The University of Chicago, Chicago, USA

3Nanyang Technological University, Singapore, Singapore

4Zhejiang Chinese Medical University, Hangzhou, China


The Complementary and Alternative Medicine for Antithrombosis

Description

Blood stasis syndrome (BSS) or thrombosis in biomedical terms, which refers to the blockage in the circulation of blood, is attributed to a very complicated pathogenesis which mainly involves hemorheology disorder, microcirculatory disturbance, vascular endothelial cell injury, and platelet aggregation. It is well known that traditional Chinese medicine (TCM) has a long history for treating thrombosis or BBS. However, the basic and clinical significance of TCM on antithrombosis are not sufficiently visible yet. Therefore, further evidence-based research of the complementary and alternative medicine could enhance the effectiveness in antithrombotic therapies.

We invite authors to contribute original research and review articles that will stimulate basic research, clinical practice, and clinical research of complementary and alternative medicine for antithrombosis. In this special issue, we take particular interest in manuscripts that evaluate and discuss the rationale, methods, mechanisms, clinical practice guidelines, or expert consensus of complementary and alternative medicine for antithrombotic and related therapies.

Potential topics include, but are not limited to:

  • Recent advances of complementary and alternative medicine in antithrombosis
  • The use of complementary and alternative medicine in antithrombosis therapies
  • Clinical application of natural origin thrombotic inhibitors in the treatment of blood stasis syndrome
  • SAR studies (structure/activity relationship) of antithrombotic natural compounds
  • Natural substances as lead compounds for new drugs in antithrombosis
Evidence-Based Complementary and Alternative Medicine
 Journal metrics
Acceptance rate27%
Submission to final decision68 days
Acceptance to publication33 days
CiteScore2.900
Impact Factor1.813
 Submit

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.